Volumetric analysis versus response evaluation criteria in solid tumors and modified response evaluation criteria in solid tumors in the evaluation of HCC after transarterial chemoembolization
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F16%3A00092221" target="_blank" >RIV/00216224:14110/16:00092221 - isvavai.cz</a>
Výsledek na webu
<a href="http://paperity.org/p/76277811/esgar-2016-book-of-abstracts" target="_blank" >http://paperity.org/p/76277811/esgar-2016-book-of-abstracts</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s13244-016-0502-9" target="_blank" >10.1007/s13244-016-0502-9</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Volumetric analysis versus response evaluation criteria in solid tumors and modified response evaluation criteria in solid tumors in the evaluation of HCC after transarterial chemoembolization
Popis výsledku v původním jazyce
Purpose of this study is to compare volumetric analysis with the standard criteria - response evaluation criteria in solid tumors (RECIST) and modified response evaluation criteria in solid tumors (mRECIST) - for the evaluation of HCC and its response to transarterial chemoembolization (TACE). The total of 40 patients was included in the study. Volumetric analysis was statistically proven the strongest factor of the correlation with the length of the survival of the patients, contrary to RECIST and mRECIST. It is a convenient way to evaluate the response of HCC to treatment, particularly in complex tumors after TACE.
Název v anglickém jazyce
Volumetric analysis versus response evaluation criteria in solid tumors and modified response evaluation criteria in solid tumors in the evaluation of HCC after transarterial chemoembolization
Popis výsledku anglicky
Purpose of this study is to compare volumetric analysis with the standard criteria - response evaluation criteria in solid tumors (RECIST) and modified response evaluation criteria in solid tumors (mRECIST) - for the evaluation of HCC and its response to transarterial chemoembolization (TACE). The total of 40 patients was included in the study. Volumetric analysis was statistically proven the strongest factor of the correlation with the length of the survival of the patients, contrary to RECIST and mRECIST. It is a convenient way to evaluate the response of HCC to treatment, particularly in complex tumors after TACE.
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
FP - Ostatní lékařské obory
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů